FITC anti-human CD19 Recombinant Antibody, CD19, QA18A75,BioLegend,309507
From in-house testing, clone QA18A75 blocks binding of clone HIB19 on target cells.
Host
Mouse
Reactivity
Human
Application
FC - Quality tested
Platform ID
BAB394345090
BioLegend
Contact
Tel: 1-858-455-9588
Fax: +49 (4131) 7023913
Email:
Product Specifications
Scientific Background
Specifications
NameFITC anti-human CD19 Recombinant Antibody, CD19, QA18A75
Cat. No.309507
HostMouse
RRIDAB_2927865 (BioLegend Cat. No. 309507)AB_2927865 (BioLegend Cat. No. 309508)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityRecombinant
Clone NumberQA18A75
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD19
PurityThe antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only
Scientific Background
DescriptionCD19, also known as B4, is a 95 kD type I transmembrane glycoprotein. It is a member of the immunoglobulin superfamily expressed on B-cells (from pro-B to blastoid B cells, absent on plasma cells) and follicular dendritic cells. CD19 is involved in B cell development, activation, and differentiation. CD19 forms a complex with CD21 (CR2) and CD81 (TAPA-1), and functions as a BCR co-receptor.Product Details
Category Paths
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.